Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06913881
What this trial is testing

Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Karolinska Institutet 92,100
Not applicableStudy completedNCT07360262
What this trial is testing

Gastric Emptying Recovery After GLP-1 RA Cessation

Who this might be right for
Gastric EmptyingGastroparesisPreoperative Care
Wonkwang University Hospital 186
Not applicableStudy completedNCT03502083
What this trial is testing

Human Vasodilatory Effect of GLP-1

Who this might be right for
Coronary StenosisType2 DiabetesAngina, Stable
Papworth Hospital NHS Foundation Trust 11
Testing effectiveness (Phase 2)Study completedNCT06867718
What this trial is testing

Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions

Who this might be right for
Obesity or Overweight
Regor Pharmaceuticals Inc. 267
Testing effectiveness (Phase 2)Study completedNCT06987513
What this trial is testing

RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight

Who this might be right for
Alcohol Use Disorder (AUD)
Altimmune, Inc. 100
Not applicableLooking for participantsNCT06790160
What this trial is testing

Study of Patients Being Treated With Anti-obesity Medication

Who this might be right for
Obesity and Overweight
Texas Tech University 100
Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Not applicableUnknownNCT01729299
What this trial is testing

Ghrelin Effect on Beta Cell Function in Health and Disease

Who this might be right for
Diabetes
David Dalessio 30
Early research (Phase 1)UnknownNCT03182192
What this trial is testing

GLP1R-imaging in Hypoglycemia

Who this might be right for
Hypoglycemia
Radboud University Medical Center 12
Post-approval studies (Phase 4)Study completedNCT02227849
What this trial is testing

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 71
Not applicableStudy completedNCT01274052
What this trial is testing

Study of Postprandial Incretin Response in Women With Gestational Diabetes

Who this might be right for
Gestational Diabetes Mellitus
University Hospital, Gentofte, Copenhagen 19
Not applicableUnknownNCT01760772
What this trial is testing

Effect of GLP-1 on Postprandial Lipid Metabolism

Who this might be right for
Heart Disease
David Dalessio 42
Large-scale testing (Phase 3)Looking for participantsNCT07613307
What this trial is testing

Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

Who this might be right for
Diabetes Mellitus, Type 2Diabetes MelletusGlucose Metabolism Disorders+13 more
Eli Lilly and Company 130
Testing effectiveness (Phase 2)Study completedNCT06854952
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity

Who this might be right for
Overweight or Obesity
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 167
Testing effectiveness (Phase 2)Study completedNCT00566358
What this trial is testing

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

Who this might be right for
Diabetes Mellitus, Type 2
University of Campinas, Brazil 18
Testing effectiveness (Phase 2)UnknownNCT06057077
What this trial is testing

Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus

Who this might be right for
Type 1 Diabetes
Ministry of Health, Saudi Arabia 120
Not applicableUnknownNCT04134156
What this trial is testing

Sleeve Gastrectomy Versus One-anastomosis Gastric Bypass: Randomized Trial

Who this might be right for
Morbid Obesity
Mansoura University 40
Not applicableStudy completedNCT06911073
What this trial is testing

Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

Who this might be right for
Obesity and Overweight
ResBiotic Nutrition, Inc. 80
Large-scale testing (Phase 3)UnknownNCT02847403
What this trial is testing

Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients

Who this might be right for
DysglycemiaCognitive Deficit
Azienda Ospedaliero-Universitaria di Parma 40
Post-approval studies (Phase 4)Study completedNCT07374445
What this trial is testing

Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

Who this might be right for
ObesityWeight LossBariatric Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Next Page